www.amarnatherapeutics.com www.nxbio.com Key Highlights: Fast-Tracking Clinical Readiness: The agreement enables process and analytical development activities required to advance Nimvec™ AM510 for Type 1 Diabetes toward cGMP manufacturing and first-in-human clinical trialsStrengthening the Amarna–NorthX Biologics Alliance: This milestone marks a significant step forward in the companies’…
Latest News
Editor' Pick
Bellingham, WA, July 08, 2025 (GLOBE NEWSWIRE) — The Non-GMO Project announced…
Just In
CHICAGO, July 08, 2025 (GLOBE NEWSWIRE) — Oil-Dri Corporation of America (NYSE:…
Canada News
Rents continued to fall across Canada in June, marking the ninth straight month of rent decreases across the country, the National Rent Report from…
Entertainment
Denise Richards and Aaron Phypers have split up after six years of…